Chemerin As A Non-Invasive Serum Marker for Non-Alcoholic Fatty Liver Disease

Background: Attempts have been made to recognize noninvasive markers for the identification of non-alcoholic fatty liver disease (NAFLD). Chemerin is a newly defined adipokine linked insulin resistance and adipogenesis. Objective: This study intended evaluate diagnostic ability serum chemerin compared with NAFLD fibrosis score as marker diagnosis grading NAFLD. Patients methods: We enrolled 60 patients categorized them into 3 subgroups based on grade by ultrasound. Thirty healthy participants were recruited control group. ELISA method was used levels measurement. Results: Serum significantly higher in cases than controls (p ? 0.001). Furthermore, these positively correlated comparable regards Patients within gray zone had comparison under 0.001). Conclusion: Serum promising diagnosing NAFLD. More research required determine its definitive clinical benefit